{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:42:30Z","timestamp":1769280150445,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1124\/dmd.117.075614","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T00:10:36Z","timestamp":1492474236000},"page":"834-845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Modeling Combined Immunosuppressive and Anti-inflammatory Effects of Dexamethasone and Naproxen in Rats Predicts the Steroid-Sparing Potential of Naproxen"],"prefix":"10.1016","volume":"45","author":[{"given":"Xiaonan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra C.","family":"DuBois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Almon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Jusko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xijing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.117.075614_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF01966645","article-title":"Effects of non-steroidal anti-inflammatory drugs on lymphocyte activation","volume":"14","author":"Ali","year":"1984","journal-title":"Agents Actions"},{"key":"10.1124\/dmd.117.075614_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0006-2952(79)90112-6","article-title":"Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle","volume":"28","author":"Bayer","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.117.075614_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00195907","article-title":"Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid","volume":"46","author":"Bertin","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.117.075614_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10928-012-9280-2","article-title":"Applications of minimal physiologically-based pharmacokinetic models","volume":"39","author":"Cao","year":"2012","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/dmd.117.075614_bib6","doi-asserted-by":"crossref","first-page":"re9","DOI":"10.1126\/stke.2002.138.re9","article-title":"Rapid actions of steroid receptors in cellular signaling pathways","volume":"2002","author":"Cato","year":"2002","journal-title":"Sci STKE"},{"key":"10.1124\/dmd.117.075614_bib7","first-page":"113","article-title":"Pathways to chronic inflammation in rheumatoid synovitis","volume":"46","author":"Cavender","year":"1987","journal-title":"Fed Proc"},{"key":"10.1124\/dmd.117.075614_bib8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/jps.3000","article-title":"Pharmacodynamic interaction of recombinant human interleukin-10 and prednisolone using in vitro whole blood lymphocyte proliferation","volume":"91","author":"Chakraborty","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.075614_bib9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.bjp.0703449","article-title":"NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund\u2019s adjuvant arthritis","volume":"130","author":"Cicala","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.117.075614_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/dmd.117.075614_bib11","doi-asserted-by":"crossref","unstructured":"Coxib and Traditional NSAID Trialists\u2019 (CNT) CollaborationBhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA et al. (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382:769\u2013779.","DOI":"10.1016\/S0140-6736(13)60900-9"},{"issue":"Suppl 3","key":"10.1124\/dmd.117.075614_bib12","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1124\/dmd.117.075614_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/106002809002400301","article-title":"Characterization of dexamethasone binding in normal and uremic human serum","volume":"24","author":"Cummings","year":"1990","journal-title":"DICP"},{"key":"10.1124\/dmd.117.075614_bib14","first-page":"2295","article-title":"Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations","volume":"22","author":"Day","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1124\/dmd.117.075614_bib15","series-title":"Adapt 5 User\u2019s Guide: Pharmacokinetic\/Pharmacodynamic Systems Analysis Software, BMSR","author":"D\u2019Argenio","year":"2009"},{"key":"10.1124\/dmd.117.075614_bib16","doi-asserted-by":"crossref","first-page":"ra74","DOI":"10.1126\/scisignal.2001077","article-title":"Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence","volume":"3","author":"Duma","year":"2010","journal-title":"Sci Signal"},{"key":"10.1124\/dmd.117.075614_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF01061691","article-title":"Comparison of four basic models of indirect pharmacodynamic responses","volume":"21","author":"Dayneka","year":"1993","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.117.075614_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10928-004-8319-4","article-title":"Assessment of drug interactions relevant to pharmacodynamic indirect response models","volume":"31","author":"Earp","year":"2004","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/dmd.117.075614_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s11095-008-9711-3","article-title":"Quantitative dynamic models of arthritis progression in the rat","volume":"26","author":"Earp","year":"2009","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.117.075614_bib20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1124\/jpet.108.137414","article-title":"Modeling corticosteroid effects in a rat model of rheumatoid arthritis II: mechanistic pharmacodynamic model for dexamethasone effects in Lewis rats with collagen-induced arthritis","volume":"326","author":"Earp","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.075614_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1124\/jpet.108.137372","article-title":"Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats","volume":"326","author":"Earp","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.075614_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/bdd.626","article-title":"Pharmacokinetics of dexamethasone in a rat model of rheumatoid arthritis","volume":"29","author":"Earp","year":"2008","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.117.075614_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-3565(24)37575-5","article-title":"Species- and gender-related differences in cyclosporine\/prednisolone\/sirolimus interactions in whole blood lymphocyte proliferation assays","volume":"286","author":"Ferron","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.075614_bib24","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2146\/ajhp050514","article-title":"Treatment of rheumatoid arthritis","volume":"63","author":"Gaffo","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"10.1124\/dmd.117.075614_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1074\/jbc.M107228200","article-title":"Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor","volume":"277","author":"Gerbal-Chaloin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.117.075614_bib26","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1084\/jem.146.6.1719","article-title":"Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell","volume":"146","author":"Goodwin","year":"1977","journal-title":"J Exp Med"},{"key":"10.1124\/dmd.117.075614_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1034\/j.1600-065x.2001.1840117.x","article-title":"Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis","volume":"184","author":"Holmdahl","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1124\/dmd.117.075614_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/03009747709095441","article-title":"Naproxen concentrations in serum, synovial fluid, and synovium","volume":"6","author":"Jalava","year":"1977","journal-title":"Scand J Rheumatol"},{"key":"10.1124\/dmd.117.075614_bib29","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1002\/art.22120","article-title":"Influence of male sex on disease phenotype in familial rheumatoid arthritis","volume":"54","author":"Jawaheer","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1124\/dmd.117.075614_bib30","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4049\/jimmunol.122.4.1563","article-title":"Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway","volume":"122","author":"Kelly","year":"1979","journal-title":"J Immunol"},{"key":"10.1124\/dmd.117.075614_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199507203330302","article-title":"The effect of glucocorticoids on joint destruction in rheumatoid arthritis","volume":"333","author":"Kirwan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.117.075614_bib33","first-page":"710","article-title":"Relationships between biophasic disposition and pharmacokinetic behavior in nonsteroid antiinflammatory drugs","volume":"36","author":"Lauroba","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/dmd.117.075614_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/dmd.116.074500","article-title":"Effect of disease-related changes in plasma albumin on the pharmacokinetics of naproxen in male and female arthritic rats","volume":"45","author":"Li","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.075614_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1124\/dmd.116.074526","article-title":"Modeling sex differences in pharmacokinetics, pharmacodynamics, and disease progression effects of naproxen in rats with collagen-induced arthritis","volume":"45","author":"Li","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.075614_bib36","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s11095-011-0396-7","article-title":"Pharmacokinetic-pharmacodynamic disease progression model for effect of etanercept in Lewis rats with collagen-induced arthritis","volume":"28","author":"Lon","year":"2011","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.117.075614_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/cpt1978234402","article-title":"Gastrointestinal microbleeding after aspirin and naproxen","volume":"23","author":"Lussier","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.117.075614_bib38","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/jps.10402","article-title":"Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation","volume":"92","author":"Mager","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.075614_bib39","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.117.075614_bib40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jps.2600720735","article-title":"Fraction unbound in interstitial fluid","volume":"72","author":"McNamara","year":"1983","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.075614_bib41","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0006-2952(96)85085-4","article-title":"Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic O-demethylation of R- and S-naproxen","volume":"51","author":"Miners","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.117.075614_bib42","unstructured":"National Research Council (NRC) (2011) Guide for the Use and Care of Laboratory Animals. 8th ed. National Academies Press, Washington, DC."},{"key":"10.1124\/dmd.117.075614_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00003088-198917030-00002","article-title":"Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid","volume":"17","author":"Netter","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.117.075614_bib44","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/art.1780190512","article-title":"Effects of certain antirheumatic drugs on normal human peripheral blood lymphocytes. Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine","volume":"19","author":"Panush","year":"1976","journal-title":"Arthritis Rheum"},{"key":"10.1124\/dmd.117.075614_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E","article-title":"A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery","volume":"89","author":"Poulin","year":"2000","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.075614_bib46","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/dmd.117.075614_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","article-title":"Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events","volume":"96","author":"Saag","year":"1994","journal-title":"Am J Med"},{"key":"10.1124\/dmd.117.075614_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/bdd.435","article-title":"Comparison of dexamethasone pharmacokinetics in female rats after intravenous and intramuscular administration","volume":"26","author":"Samtani","year":"2005","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.117.075614_bib49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bmc.788","article-title":"Quantification of dexamethasone and corticosterone in rat biofluids and fetal tissue using highly sensitive analytical methods: assay validation and application to a pharmacokinetic study","volume":"21","author":"Samtani","year":"2007","journal-title":"Biomed Chromatogr"},{"key":"10.1124\/dmd.117.075614_bib50","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0022-3565(25)25053-4","article-title":"Inhibition of amino acid transport by nonsteroidal anti-inflammatory drugs: a model for predicting relative therapeutic potency","volume":"237","author":"Seng","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.075614_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2999(90)90105-F","article-title":"Changes in T and B lymphocyte proliferative responses in adjuvant-arthritic rats: antagonism by indomethacin","volume":"178","author":"Seng","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.117.075614_bib52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10928-011-9232-2","article-title":"Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human","volume":"39","author":"Shah","year":"2012","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/dmd.117.075614_bib53","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1124\/dmd.117.075614_bib54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0960-0760(97)00038-1","article-title":"Dexamethasone metabolism in vitro: species differences","volume":"62","author":"Tomlinson","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/dmd.117.075614_bib55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/342082a0","article-title":"Interleukin-2-dependent autocrine proliferation in T-cell development","volume":"342","author":"Toribio","year":"1989","journal-title":"Nature"},{"key":"10.1124\/dmd.117.075614_bib56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2125.1987.tb03028.x","article-title":"Naproxen pharmacokinetics in patients with rheumatoid arthritis during active polyarticular inflammation","volume":"23","author":"van den Ouweland","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.117.075614_bib57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1741-7015-7-12","article-title":"Sex differences in rheumatoid arthritis: more than meets the eye...","volume":"7","author":"van Vollenhoven","year":"2009","journal-title":"BMC Med"},{"key":"10.1124\/dmd.117.075614_bib58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1124\/dmd.117.075614_bib59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cbi.2008.10.035","article-title":"Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes","volume":"179","author":"Vrzal","year":"2009","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.117.075614_bib60","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archinte.162.10.1105","article-title":"Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis","volume":"162","author":"Watson","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1124\/dmd.117.075614_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10928-009-9128-6","article-title":"Methods of utilizing baseline values for indirect response models","volume":"36","author":"Woo","year":"2009","journal-title":"J Pharmacokinet Pharmacodyn"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.117.075614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:30:03Z","timestamp":1739903403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624053881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0090955624053881"],"URL":"https:\/\/doi.org\/10.1124\/dmd.117.075614","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling Combined Immunosuppressive and Anti-inflammatory Effects of Dexamethasone and Naproxen in Rats Predicts the Steroid-Sparing Potential of Naproxen","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.117.075614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}